COPENHAGEN, Denmark, Sept. 29, 2026 -- Breye Therapeutics ApS (Breye), a clinical-stage biopharmaceutical company developing oral therapeutics for the early treatment of retinal diseases, today announced the successful close of...
Sensys Medical
Sensys developed a non-invasive blood glucose monitor that used near infrared diffuse reflectance spectroscopy. The technology was designed to provide a painless method to collect data for proactive use in controlling diabetes.
Sensys Medical
Chandler, AZ
